missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PPAP2B (aa 146-195) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (96%), Rat (96%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-83041 (PA5-83041. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Human vascular endothelial growth factor produced in E.Coli is a double, non-glycosylated, polypeptide chain containing 165 amino acids and having a molecular mass of 38231 Dalton. The rHuVEGF is purified by proprietary chromatographic techniques.
Specifications
Specifications
| Accession Number | O14495 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 8613 |
| Name | Human PPAP2B (aa 146-195) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1110003O22Rik; 2610002D05Rik; AV025606; D4Bwg0538e; D4Bwg1535e; differentially expressed in rat intestine 42; Dri42; EC 3.1.3.4; ER transmembrane protein Dri 42; lipid phosphate phosphohydrolase 3; Lpp3; MGC15306; PAP2 beta; PAP2B; PAP-2 b; PAP2-b; PAP2-beta; phosphatidate phosphohydrolase type 2 b; Phosphatidic acid phosphatase 2 b; phosphatidic acid phosphatase type 2 B; phospholipid phosphatase 3; PLPP3; Ppab2b; PPAP2B; type-2 phosphatidic acid phosphatase-beta; vascular endothelial growth factor and type I collagen inducible; Vascular endothelial growth factor and type I collagen-inducible protein; VCIP |
| Common Name | PPAP2B |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction